Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b.

MLA

Ogasawara, Nobuhiko, et al. “Serial Changes in Liver Stiffness and Controlled Attenuation Parameter Following Direct-Acting Antiviral Therapy against Hepatitis C Virus Genotype 1b.” Journal of Medical Virology, vol. 90, no. 2, Feb. 2018, pp. 313–19. EBSCOhost, https://doi.org/10.1002/jmv.24950.

APA

Ogasawara, N., Kobayashi, M., Akuta, N., Kominami, Y., Fujiyama, S., Kawamura, Y., Sezaki, H., Hosaka, T., Suzuki, F., Saitoh, S., Suzuki, Y., Arase, Y., Ikeda, K., Kobayashi, M., & Kumada, H. (2018). Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b. Journal of Medical Virology, 90(2), 313–319. https://doi.org/10.1002/jmv.24950

Chicago

Ogasawara, Nobuhiko, Masahiro Kobayashi, Norio Akuta, Yoko Kominami, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, et al. 2018. “Serial Changes in Liver Stiffness and Controlled Attenuation Parameter Following Direct-Acting Antiviral Therapy against Hepatitis C Virus Genotype 1b.” Journal of Medical Virology 90 (2): 313–19. doi:10.1002/jmv.24950.